for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Thermo Fisher Scientific Inc.

TMO.N

Latest Trade

297.08USD

Change

-12.08(-3.91%)

Volume

666,292

Today's Range

297.01

 - 

311.31

52 Week Range

246.67

 - 

342.25

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
309.16
Open
304.00
Volume
666,292
3M AVG Volume
27.50
Today's High
311.31
Today's Low
297.01
52 Week High
342.25
52 Week Low
246.67
Shares Out (MIL)
400.99
Market Cap (MIL)
123,970.40
Forward P/E
--
Dividend (Yield %)
0.28

Next Event

Thermo Fisher Scientific Inc at Cowen HealthCare Conference

Latest Developments

More

Thermo Fisher Scientific Elected CEO Marc Casper As Chairman, Effective Immediately

Thermo Fisher Scientific Says Authorized Qtrly Cash Dividend Of $0.22/Shr

Thermo Fisher Scientific Q4 Revenue Increased 5% To $6.83 Billion

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. It offers its products and services through various brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services. Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines. Analytical Instruments segment provides a broad offering of instruments, consumables, software and services that are used for a range of applications in the laboratory. Specialty Diagnostics segment offers a wide range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Services segment offers products and solutions needed for the laboratory.

Contact Info

168 3rd Ave

+1.781.6221000

https://www.thermofisher.com/

Executive Leadership

Jim P. Manzi

Independent Chairman of the Board

Marc N. Casper

President, Chief Executive Officer, Director

Stephen Williamson

Chief Financial Officer, Senior Vice President

Mark P. Stevenson

Chief Operating Officer, Executive Vice President

Michael A. Boxer

Senior Vice President, General Counsel

Key Stats

1.74 mean rating - 19 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

20.9K

2018

24.4K

2019

25.5K

2020(E)

26.9K
EPS (USD)

2017

9.490

2018

11.120

2019

12.350

2020(E)

13.609
Price To Earnings (TTM)
33.63
Price To Sales (TTM)
4.85
Price To Book (MRQ)
4.18
Price To Cash Flow (TTM)
20.73
Total Debt To Equity (MRQ)
59.82
LT Debt To Equity (MRQ)
57.54
Return on Investment (TTM)
7.26
Return on Equity (TTM)
6.47

Latest News

Latest News

BRIEF-Thermo Fisher Scientific Elected CEO Marc Casper As Chairman, Effective Immediately

* THERMO FISHER SCIENTIFIC PRESIDENT AND CHIEF EXECUTIVE OFFICER MARC N. CASPER ELECTED CHAIRMAN OF THE BOARD OF DIRECTORS

BRIEF-Thermo Fisher Scientific Says Authorized Qtrly Cash Dividend Of $0.22/Shr

* THERMO FISHER SCIENTIFIC INC - AUTHORIZED A QUARTERLY CASH DIVIDEND OF $0.22 PER COMMON SHARE

Qiagen exploring sale after indications of interest

Qiagen NV <QGEN.O> said on Friday it has started reviewing options, including sale, after the genetic testing company received several indications of interest for acquisition, sending its U.S. listed shares up 8.5%.

Thermo Fisher approaches genetic testing specialist Qiagen for deal: Bbg

Instruments maker Thermo Fisher Scientific Inc <TMO.N> has approached genetic testing specialist Qiagen NV <QIA.DE> <QGEN.N> about a potential deal, Bloomberg https://www.bloomberg.com/news/articles/2019-11-13/thermo-fisher-said-to-weigh-purchase-of-diagnostics-firm-qiagen...

Ametek to buy Roper Tech's unit for $925 million

Electronic instruments maker Ametek Inc <AME.N> said on Friday it would buy a unit of Roper Technologies Inc <ROP.N>, Gatan Inc, for $925 million in cash, a few months after Thermo Fisher Scientific Inc <TMO.N> scrapped its plan to buy the business.

Thermo Fisher, Danaher among firms competing for KKR's LGC Group: Bloomberg

Medical device makers Thermo Fisher Scientific Inc <TMO.N> and Danaher Corp <DHR.N> have expressed interest in KKR & Co's <KKR.N> potential sale of its scientific measurement and testing company LGC Group, Bloomberg reported on Friday.

Thermo Fisher misses organic revenue growth estimates, shares fall

Thermo Fisher Scientific Inc <TMO.N> missed Wall Street estimates for quarterly organic revenue growth on Wednesday, hurt by an outage at one of its data centers, sending the company's shares down as much as 4.9%.

Thermo Fisher raises full-year forecasts as life sciences drives quarterly profit

Thermo Fisher Scientific Inc reported second-quarter profit that beat Wall Street estimates and raised its 2019 forecast for sales and profit on Wednesday, helped by a 9% rise in sales at its life sciences unit.

Thermo Fisher scraps Roper deal after U.K. antitrust hurdle

Thermo Fisher Scientific Inc and Roper Technologies Inc said on Monday they have mutually agreed to terminate Thermo Fisher's deal to buy Roper's unit Gatan Inc owing to challenges in obtaining regulatory approval in the United Kingdom.

Thermo Fisher, Roper agree to terminate $925 million deal

Thermo Fisher Scientific Inc and Roper Technologies Inc on Monday said they have mutually agreed to terminate Thermo Fisher's deal to buy Roper's unit Gatan Inc.

Thermo Fisher raises 2019 forecasts, beats first quarter profit estimates

Thermo Fisher Scientific Inc on Wednesday raised its 2019 forecasts for adjusted profit and revenue on the back of its $1.7 billion (£1.3 billion) deal to buy Brammer Bio, and beat the average analyst estimate for first-quarter profit.

Thermo Fisher to acquire Brammer Bio in $1.7 billion deal

Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, said on Sunday it has agreed to buy Brammer Bio in a roughly $1.7 billion cash deal.

Thermo Fisher to acquire Brammer Bio in $1.7 bln deal

Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, said on Sunday it has agreed to buy Brammer Bio in a roughly $1.7 billion cash deal.

Thermo Fisher to sell pathology unit for $1.14 billion

Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, will sell its anatomical pathology business for $1.14 billion in cash, the company said on Monday.

UK competition watchdog to take a deeper look at Thermo Fisher Roper deal

Thermo Fisher Scientific Inc's <TMO.N> proposed $925 million (725.89 million pounds) acquisition of Roper Technologies Inc's unit <ROP.N> will be referred for a deeper phase two investigation, Britain's competition watchdog said on Monday.

UK competition watchdog puts Thermo Fisher-Roper deal under the microscope

Britain's competition watchdog said on Wednesday Thermo Fisher Scientific Inc's <TMO.N> $925 million acquisition of Roper Technologies Inc's <ROP.N> unit Gatan raised concerns that prices of microscopes could go up and quality could suffer.

UK competition watchdog puts Thermo Fisher-Roper deal under the microscope

Britain's competition watchdog said on Wednesday Thermo Fisher Scientific Inc's $925 million acquisition of Roper Technologies Inc's unit Gatan raised concerns that prices of specialist microscopes could go up and quality could decline.

Thermo Fisher raises forecast after third-quarter profit beat

Thermo Fisher Scientific Inc <TMO.N> reported a better-than-expected quarterly profit on Wednesday on higher demand for its laboratory products and the world's largest scientific instruments maker raised its full-year forecast.

Thermo Fisher raises forecast after second-quarter beat

Thermo Fisher Scientific Inc <TMO.N> posted a better-than-expected quarterly profit as its laboratory products division received a boost from a recent acquisition, and the company raised its 2018 forecast.

Thermo Fisher to buy Roper Technologies unit for $925 million

Thermo Fisher Scientific Inc <TMO.N>, the world's largest maker of scientific instruments, said on Thursday it would buy IT services provider Roper Technologies Inc's <ROP.N> unit Gatan Inc for about $925 million in cash.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up